Cleviprex is a Intravenous Emulsion in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Clevidipine.
Product ID | 10122-611_02b98b53-8d6d-46e5-85f3-5ec9e7b6360d |
NDC | 10122-611 |
Product Type | Human Prescription Drug |
Proprietary Name | Cleviprex |
Generic Name | Clevipidine |
Dosage Form | Emulsion |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2008-09-15 |
Marketing Category | NDA / NDA |
Application Number | NDA022156 |
Labeler Name | Chiesi USA, Inc. |
Substance Name | CLEVIDIPINE |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2008-09-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022156 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-09-15 |
Marketing Category | NDA |
Application Number | NDA022156 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-09-15 |
Ingredient | Strength |
---|---|
CLEVIDIPINE | .5 mg/mL |
SPL SET ID: | f9290625-b723-4eda-bab8-a97bef6041f6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
10122-610 | Cleviprex | clevipidine |
10122-611 | Cleviprex | clevipidine |
10122-612 | Cleviprex | clevipidine |
18124-011 | Cleviprex | clevidipine |
65293-005 | Cleviprex | clevidipine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CLEVIPREX 90349617 not registered Live/Pending |
CHIESI FARMACEUTICI S.P.A. 2020-11-30 |
CLEVIPREX 87442641 not registered Live/Pending |
Chiesi Farmaceutici S.P.A. 2017-05-09 |
CLEVIPREX 77032009 3540746 Live/Registered |
CHIESI FARMACEUTICI S.P.A. 2006-10-30 |